Sutra™ - Levelling Up AI Research & Technology

Adnexus is proud to introduce and implement the latest Artificial Intelligence innovations in research and development technology – keeping the company at the forefront of early drug discovery and development and other revolutionary discoveries critical to the treatment of infectious diseases.

Bridging Biology & Technology

Pioneering Tomorrow’s Healthcare Solutions

At Adnexus, we recognize the significance of combining biology, technology, and innovation in the fight against diseases. We can achieve remarkable feats by merging the natural blueprint with technological creativity and embracing innovation within nature’s design. Our primary objective is to bring about positive change in the lives of individuals affected by illnesses.

Commitment to Infectious Diseases

Adnexus has developed a unique and innovative approach to producing antibodies that target specific sites on viruses.

Read More

Sutra™ AI Platform

Sutra™ has helped Adnexus move forward expeditiously with the monoclonal antibody discovery and development.

Read More

Adnexus NatureScript

Dedicated to harnessing the therapeutic properties of botanicals to create health supplements and remedies.

Read More

Adnexus One

The One Health approach emphasizes the interconnectedness of human, animal, and environmental health.

Read More
Image link

Our mission

Our mission is to combat infectious diseases by developing effective diagnostic tools, treatments, and vaccines. Our ultimate goal is to ensure these solutions are accessible and affordable to all our patients.

At Adnexus, we firmly believe that integrating biology, technology, and innovation is imperative in the fight against diseases. As a dedicated drug development company, we aim to diagnose, prevent, and treat various illnesses through various platforms.

Our wholly owned Artificial Intelligence Platform facilitates early drug discovery and development while aiding in creating an intellectual property portfolio. Furthermore, our AI-empowered Monoclonal Antibody Platform is dedicated to developing species-specific monoclonal antibodies for human and animal use.

Our company operates at our lab based at the University of Missouri. This facility utilizes our AI platform, Sutra™, to produce multiple monoclonal antibodies for various infectious diseases.

Our partners around the world

Adnexus is committed to providing accessible and affordable therapeutic solutions. We collaborate with other biotechnology, pharmaceutical companies, and institutions to achieve this goal, expediting the lab-to-clinical journey for these therapeutic solutions.